663 related articles for article (PubMed ID: 26181236)
1. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Orbital Recurrence After Enucleation or Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma.
de Jong MC; Kors A; de Graaf P
JAMA Ophthalmol; 2016 Jan; 134(1):114. PubMed ID: 26583950
[No Abstract] [Full Text] [Related]
3. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.
Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP
Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Orbital Recurrence After Enucleation or Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma--Reply.
Yannuzzi NA; Francis JH; Abramson DH
JAMA Ophthalmol; 2016 Jan; 134(1):114-5. PubMed ID: 26584063
[No Abstract] [Full Text] [Related]
5. Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy.
Francis JH; Roosipu N; Levin AM; Brodie SE; Dunkel IJ; Gobin YP; Abramson DH
Neoplasia; 2018 Aug; 20(8):757-763. PubMed ID: 29940303
[TBL] [Abstract][Full Text] [Related]
6. Ophthalmic artery chemosurgery for retinoblastoma prevents new intraocular tumors.
Abramson DH; Francis JH; Dunkel IJ; Marr BP; Brodie SE; Gobin YP
Ophthalmology; 2013 Mar; 120(3):560-565. PubMed ID: 23177361
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
[TBL] [Abstract][Full Text] [Related]
8. Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC.
Abramson DH; Fabius AW; Issa R; Francis JH; Marr BP; Dunkel IJ; Gobin YP
PLoS One; 2015; 10(12):e0145436. PubMed ID: 26709699
[TBL] [Abstract][Full Text] [Related]
9. Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival.
Francis JH; Levin AM; Zabor EC; Gobin YP; Abramson DH
PLoS One; 2018; 13(5):e0197081. PubMed ID: 29791475
[TBL] [Abstract][Full Text] [Related]
10. Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review.
Abramson DH; Marr BP; Brodie SE; Dunkel I; Palioura S; Gobin YP
PLoS One; 2012; 7(4):e34120. PubMed ID: 22545080
[TBL] [Abstract][Full Text] [Related]
11. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
12. Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.
Francis JH; Iyer S; Gobin YP; Brodie SE; Abramson DH
Ophthalmology; 2017 Oct; 124(10):1548-1555. PubMed ID: 28545735
[TBL] [Abstract][Full Text] [Related]
13. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
[TBL] [Abstract][Full Text] [Related]
14. Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma.
Abramson DH; Daniels AB; Marr BP; Francis JH; Brodie SE; Dunkel IJ; Gobin YP
PLoS One; 2016; 11(1):e0146582. PubMed ID: 26756643
[TBL] [Abstract][Full Text] [Related]
15. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy).
Abramson DH; Marr BP; Francis JH; Dunkel IJ; Fabius AW; Brodie SE; Mondesire-Crump I; Gobin YP
PLoS One; 2016; 11(6):e0156806. PubMed ID: 27258771
[TBL] [Abstract][Full Text] [Related]
17. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
[TBL] [Abstract][Full Text] [Related]
18. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
Brennan RC; Qaddoumi I; Billups CA; Free TL; Haik BG; Rodriguez-Galindo C; Wilson MW
Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
[TBL] [Abstract][Full Text] [Related]
19. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
Berry JL; Kogachi K; Aziz HA; McGovern K; Zolfaghari E; Murphree AL; Jubran R; Kim JW
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
[TBL] [Abstract][Full Text] [Related]
20. Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments.
Venturi C; Bracco S; Cerase A; Cioni S; Galluzzi P; Gennari P; Vallone IM; Tinturini R; Vittori C; De Francesco S; Caini M; D'Ambrosio A; Toti P; Renieri A; Hadjistilianou T
Acta Ophthalmol; 2013 Jun; 91(4):335-42. PubMed ID: 22268993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]